CIRS Competitors and Similar CompaniesClear all
Viewpoint Molecular Targeting's competitors and similar companies include Curasight.
 Viewpoint Molecular Targeting Viewpoint Molecular Targeting is a radiopharmaceutical company that develops alpha-particle therapy for cancer. |  Curasight Curasight is a company engaged in the field of exploiting a Positron Emissions Tomography (PET) imaging platform targeting the urokinase-type plasminogen activator receptor (uPAR). | |
Founding Date | Founding Date 2008 | Founding Date 2013 |
Type | Type Subsidiary | Type Private |
Tags | ||
Locations | Locations Coralville, US HQ | Locations København, DK HQ |
Employees | Employees 517% decrease | Employees 7 |
For sources of this data, please see the company profile
View Company Profiles
Curasight
HQ
København, DK
Employees
7
Curasight is a company engaged in the field of exploiting a Positron Emissions Tomography (PET) imaging platform targeting the urokinase-type plasminogen activator receptor (uPAR).
View company